Pharmaceutical Commerce

Featured Content

Pharmaceutical Commerce - August 2023

Click here to read the articles and download the PDF

Doubling Down on Drug Adherence

Creating a user-centric approach that harnesses both digital tools and behavioral science is key to getting—and maintaining—patients on therapy, and improving clinical, financial, and, ultimately, brand-success outcomes for pharma manufacturers.

Breaking the Pharma Industry’s Bundled Pricing Arrangements

How the ‘fight-for-the-dollar’ is coming and likely will impact the bundled pricing of industry stakeholders.

Wholesalers Step Up Their Partnering

Companies' emphasis on delivering pharmaceuticals is evolving into a collaboration focused on healthcare outcomes.

Novo Nordisk Partners with Aspen to Support Insulin Production in Africa

September 21, 2023

Deal aims to provide diabetes treatment to patients across the continent.

Pharmacy Technician Certification Board Survey Finds Drug Shortages Impacting Majority of Pharmacies

September 21, 2023

Nearly 96% of respondents say that this is an issue affecting their respective pharmacy.

Envirotainer Grows Network Capabilities in Americas

September 21, 2023

Expansion is expected to meet the growing market demand from the region.

Select Health, Mark Cuban Cost Plus Drug Company Partner on Lowering Prescription Drug Costs

September 20, 2023

Collaboration aims to cut medication costs for patients with conditions ranging from high blood pressure to diabetes.

Clinigen Unveils Educational Program for Rare Disease Patients and Organizations

September 20, 2023

The program to facilitate engagement between HCPs, industry, and regulatory bodies.

Acino Absorbs M8 Pharmaceuticals

September 20, 2023

Deal aims to provide diabetes treatment to patients across the continent.

Medac GmbH Furthers Its Commitment to Pharmacovigilance Tech, Partners with ArisGlobal

September 19, 2023

SaaS’ branded platform expected to help grow manufacturer’s therapeutic development processes.

Samsung Biologics Extends Manufacturing Deal with BMS

September 19, 2023

CDMO will continue to produce commercial antibody cancer drug substance, featuring a new $242 million agreement.

FDA Issues Guidance on Biosimilar Labeling

September 19, 2023

The draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.

Audio Success in Pharma

September 18, 2023

A panel at the recent Talk Health event in Philadelphia focused on what success looks like in audio from publisher, vendor, and HCP perspectives.